Skip to main content
Fig. 3 | Applied Cancer Research

Fig. 3

From: Standard of care of patients with Chronic Myeloid Leukemia (CML) treated in community based oncology group practices between 2001-2015 in Rhineland-Palatinate (Germany)

Fig. 3

Progression Free Survival (PFS) for all patients who were diagnosed in chronic phase in November 2001 or later and received a TKI as 1st line treatment. TOTAL (N = 190); median not yet reached (0.7–12.8+). Charlson Score 2 (n = 53); median not yet reached (1.7–12.6+). Charlson Score 3–4 (n = 66); median not yet reached (0.7–12.8+). Charlson Score 5–6 (n = 44); median not yet reached (0.3–11.7+). Charlson Score > 6 (n = 27); median: 5.7 years (0.4–12.5+)

Back to article page

Applied Cancer Research

ISSN: 1980-5578